Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
British Journal of Pharmacology
|
September 18, 2018
Disulfide reductase systems in liver
Colin G Miller, Edward E Schmidt
Antioxidants & Redox Signaling
|
August 18, 2020
Sulfur Metabolism Under Stress
Colin G Miller, Edward E Schmidt
Free Radical Biology & Medicine
|
April 3, 2018
NADPH-dependent and -independent disulfide reductase systems
Colin G Miller, Arne Holmgren, Elias S J Arnér, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
June 14, 2015
A DXA Whole Body Composition Cross-Calibration Experience: Evaluation With Humans, Spine, and Whole Body Phantoms
Diane Krueger, Jessie Libber, Jennifer Sanfilippo, et al.
Annals of the Rheumatic Diseases
|
April 23, 2013
Measurement error in the assessment of radiographic progression in rheumatoid arthritis (RA) clinical trials: the smallest detectable change (SDC) revisited
V Navarro-Compán, D van der Heijde, Harris A Ahmad, et al.
Rheumatology (Oxford, England)
|
January 19, 2013
Rate of adjudication of radiological progression in rheumatoid arthritis randomized controlled trials depending on preset limits of agreement: a pooled analysis from 15 randomized trials
Victoria Navarro-Compán, Robert Landewé, Harris A Ahmad, et al.
Seminars in Arthritis and Rheumatism
|
January 8, 2013
Considerations when designing a disease-modifying osteoarthritis drug (DMOAD) trial using radiography
Marie-Pierre Hellio Le Graverand, Ray S Clemmer, Robert M Brunell, et al.
Spine
|
October 16, 2009
Development of a clinical workflow tool to enhance the detection of vertebral fractures: accuracy and precision evaluation
Alan Brett, Colin G Miller, Curtis W Hayes, et al.
EJNMMI Research
|
September 6, 2021
A novel read methodology to evaluate the optimal dose of <sup>68</sup>Ga-satoreotide trizoxetan as a PET imaging agent in patients with gastroenteropancreatic neuroendocrine tumours: a phase II clinical trial
Colin G Miller, Henning Grønbæk, Irene Virgolini, et al.
Therapeutic Innovation & Regulatory Science
|
July 10, 2021
Radiologists and Clinical Trials: Part 2: Practical Statistical Methods for Understanding and Monitoring Independent Reader Performance
David L Raunig, Annette M Schmid, Colin G Miller, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
British Journal of Pharmacology
|
September 18, 2018
Disulfide reductase systems in liver
Colin G Miller, Edward E Schmidt
Antioxidants & Redox Signaling
|
August 18, 2020
Sulfur Metabolism Under Stress
Colin G Miller, Edward E Schmidt
Free Radical Biology & Medicine
|
April 3, 2018
NADPH-dependent and -independent disulfide reductase systems
Colin G Miller, Arne Holmgren, Elias S J Arnér, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
June 14, 2015
A DXA Whole Body Composition Cross-Calibration Experience: Evaluation With Humans, Spine, and Whole Body Phantoms
Diane Krueger, Jessie Libber, Jennifer Sanfilippo, et al.
Annals of the Rheumatic Diseases
|
April 23, 2013
Measurement error in the assessment of radiographic progression in rheumatoid arthritis (RA) clinical trials: the smallest detectable change (SDC) revisited
V Navarro-Compán, D van der Heijde, Harris A Ahmad, et al.
Rheumatology (Oxford, England)
|
January 19, 2013
Rate of adjudication of radiological progression in rheumatoid arthritis randomized controlled trials depending on preset limits of agreement: a pooled analysis from 15 randomized trials
Victoria Navarro-Compán, Robert Landewé, Harris A Ahmad, et al.
Seminars in Arthritis and Rheumatism
|
January 8, 2013
Considerations when designing a disease-modifying osteoarthritis drug (DMOAD) trial using radiography
Marie-Pierre Hellio Le Graverand, Ray S Clemmer, Robert M Brunell, et al.
Spine
|
October 16, 2009
Development of a clinical workflow tool to enhance the detection of vertebral fractures: accuracy and precision evaluation
Alan Brett, Colin G Miller, Curtis W Hayes, et al.
EJNMMI Research
|
September 6, 2021
A novel read methodology to evaluate the optimal dose of <sup>68</sup>Ga-satoreotide trizoxetan as a PET imaging agent in patients with gastroenteropancreatic neuroendocrine tumours: a phase II clinical trial
Colin G Miller, Henning Grønbæk, Irene Virgolini, et al.
Therapeutic Innovation & Regulatory Science
|
July 10, 2021
Radiologists and Clinical Trials: Part 2: Practical Statistical Methods for Understanding and Monitoring Independent Reader Performance
David L Raunig, Annette M Schmid, Colin G Miller, et al.
Page
of 3